Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.2750
-0.0143 (-4.94%)
At close: Nov 19, 2026, 4:00 PM EST
0.2870
+0.0120 (4.36%)
After-hours: Nov 19, 2026, 7:30 PM EST
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $43.92 million as of November 19, 2026. Its market cap has decreased by 84.84% in one year.
Market Cap
43.92M
Enterprise Value
18.40M
1-Year Change
-84.84%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from $124.83M to $43.92M, a decrease of -64.82%. That is a compound annual growth rate of -12.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 43.92M | -33.77% |
| Dec 31, 2025 | 66.31M | -87.77% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eloxx Pharmaceuticals | 47.39M |
| MiNK Therapeutics | 47.38M |
| Clene | 46.37M |
| Annovis Bio | 46.10M |
| ImageneBio | 44.27M |
| MindWalk Holdings | 42.72M |
| Actinium Pharmaceuticals | 42.45M |
| Aldeyra Therapeutics | 41.88M |